March 27, 2018 / 6:19 AM / a month ago

BRIEF-Chabiotech receives U.S. patent

March 27 (Reuters) - Chabiotech Co Ltd :

* Says it received U.S. patent on March 27, for a method for producing cardiomyocytesfrom human or mouse embryonic stem cellsin amedium consisting of aserum-free medium and N2 supplement

* Patent number is 13/907,967

Source text in Korean : goo.gl/dyb6cd

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below